Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 3.09B P/E - EPS this Y 28.00% Ern Qtrly Grth -
Income -123.41M Forward P/E -44.02 EPS next Y 41.20% 50D Avg Chg -4.00%
Sales 492.68M PEG - EPS past 5Y - 200D Avg Chg -9.00%
Dividend N/A Price/Book 13.90 EPS next 5Y - 52W High Chg -39.00%
Recommedations 1.70 Quick Ratio 1.82 Shares Outstanding 31.12M 52W Low Chg 18.00%
Insider Own 0.78% ROA -13.93% Shares Float 30.70M Beta 1.31
Inst Own 108.71% ROE -54.86% Shares Shorted/Prior 2.81M/2.47M Price 101.25
Gross Margin 67.35% Profit Margin -25.05% Avg. Volume 391,438 Target Price 139.11
Oper. Margin -19.87% Earnings Date May 2 Volume 333,044 Change -2.50%
About iRhythm Technologies, Inc.

iRhythm Technologies, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. It offers Zio services, an ambulatory monitoring solution, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. The company also provides the Zio Monitor System, a prescription-only, remote electrocardiogram (ECG) monitoring system that consists of a patch ECG monitor that records the electric signal from the heart continuously for up to 14 days and the Zio ECG Utilization Software System, which supports the capture and analysis of ECG data recorded by the Zio Monitor patch at the end of the wear period, including specific arrhythmia events detected by the ZEUS System; the Zio XT System is the previous generation of the Zio Monitor System and is a prescription-only, remote ECG monitoring system that consists of the Zio XT patch that records the electric signal from the heart continuously for up to 14 days; and the Zio AT system, a prescription-only, remote ECG monitoring system that similarly consists of the Zio AT patch that records the electric signal from the heart continuously for up to 14 days and the ZEUS System, but which also incorporates the Zio AT wireless gateway that provides connectivity between the Zio AT patch and the ZEUS System during the patient wear period. It has a development collaboration agreement with Verily Life Sciences LLC and Verity Ireland Limited to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.

iRhythm Technologies, Inc. News
04/23/24 What Makes iRhythm Technologies (IRTC) a Lucrative Investment?
04/18/24 iRhythm Technologies to Report First Quarter 2024 Financial Results on May 2, 2024
04/08/24 iRhythm Technologies (IRTC) Surges 4.2%: Is This an Indication of Further Gains?
04/05/24 Loss-Making iRhythm Technologies, Inc. (NASDAQ:IRTC) Expected To Breakeven In The Medium-Term
03/08/24 iRhythm Announces Closing of $661.25 Million of 1.50% Convertible Senior Notes Due 2029, Including Full Exercise of Initial Purchasers’ $86.25 Million Option to Purchase Additional Notes
03/05/24 Insider Sell: EVP, CMO & CSO Minang Turakhia Sells 943 Shares of iRhythm Technologies Inc (IRTC)
03/04/24 iRhythm Prices Upsized Offering of $575.0 Million of 1.50% Convertible Senior Notes Due 2029
03/04/24 iRhythm Announces Proposed Offering of $450.0 Million of Convertible Senior Notes
02/29/24 iRhythm collaborates with Epic to streamline access to Zio® service and drive more seamless connectivity between clinicians and patients
02/24/24 iRhythm Technologies Full Year 2023 Earnings: EPS Misses Expectations
02/23/24 iRhythm Technologies, Inc. (NASDAQ:IRTC) Q4 2023 Earnings Call Transcript
02/22/24 IRhythm Technologies (IRTC) Reports Q4 Loss, Tops Revenue Estimates
02/22/24 iRhythm Technologies Inc (IRTC) Reports Growth Amidst Challenges in Q4 and Full Year 2023
02/22/24 iRhythm Technologies Announces Fourth Quarter and Full Year 2023 Financial Results
02/08/24 iRhythm Technologies to Report Fourth Quarter and Full Year 2023 Financial Results on February 22, 2024
01/14/24 7 Healthcare Stocks Taking Medicine to the Next Level
01/11/24 At US$112, Is iRhythm Technologies, Inc. (NASDAQ:IRTC) Worth Looking At Closely?
01/08/24 iRhythm Technologies Shares Preliminary Fourth Quarter 2023 Highlights and Business Update at the 42nd Annual J.P. Morgan Healthcare Conference
01/05/24 Largest Ever Real-World Evidence Study of Ambulatory Cardiac Monitoring Demonstrates Clinical Superiority of iRhythm's Zio Long-Term Continuous Monitoring Service
01/04/24 iRhythm Technologies Inc Insider Sells Company Shares
IRTC Chatroom

User Image Stock_Titan Posted - 1 week ago

$IRTC iRhythm Technologies to Report First Quarter 2024 Financial Results on May 2, 2024 https://www.stocktitan.net/news/IRTC/i-rhythm-technologies-to-report-first-quarter-2024-financial-results-ugpi29j976zt.html

User Image MaverikIT Posted - 1 week ago

@IsabellaDC @DonCorleone77 @net0trader @Wigglyick @Cash4freedom @RonIsWrong @Im_not_Mr_Lebowski @JaredSotken $IRTC - getting into rhythm$

User Image Stock_Titan Posted - 1 month ago

$IRTC iRhythm Announces Closing of $661.25 Million of 1.50% Convertible Senior Notes Due 2029, Including Full Exercise of Initial Purchasers’ $86.25 Million Option to Purchase Additional Notes https://www.stocktitan.net/news/IRTC/i-rhythm-announces-closing-of-661-25-million-of-1-50-convertible-eehu51n0s85t.html

User Image topstockalerts Posted - 1 month ago

Convertible-Bond Sales Are Booming. MicroStrategy, SoFi, Albemarle Plan Deals $MSTR $SOFI $IRTC https://www.marketwatch.com/articles/convertible-bond-sales-microstrategy-sofi-cae7852b?mod=barrons-on-marketwatch

User Image Stock_Titan Posted - 1 month ago

$IRTC iRhythm Prices Upsized Offering of $575.0 Million of 1.50% Convertible Senior Notes Due 2029 https://www.stocktitan.net/news/IRTC/i-rhythm-prices-upsized-offering-of-575-0-million-of-1-50-85r2o4qln8ff.html

User Image briefingcom Posted - 1 month ago

$IRTC: iRhythm proposes offering of $450.0 million of convertible senior notes due 2029

User Image DonCorleone77 Posted - 1 month ago

$IRTC iRhythm files to sell $450M of convertible senior notes due 2029 iRhythm Technologies announced that it intends to offer, subject to market conditions and other factors, $450M aggregate principal amount of Convertible Senior Notes due 2029 in a private placement to persons reasonably believed to be qualified institutional buyers pursuant to Rule 144A under the Securities Act of 1933, as amended. iRhythm also intends to grant the initial purchasers of the notes an option to purchase, within a 13-day period from, and including, the date on which the notes are first issued, up to an additional $67.5M aggregate principal amount of notes.

User Image Stock_Titan Posted - 1 month ago

$IRTC iRhythm Announces Proposed Offering of $450.0 Million of Convertible Senior Notes https://www.stocktitan.net/news/IRTC/i-rhythm-announces-proposed-offering-of-450-0-million-of-convertible-1umryb7x8gr8.html

User Image insiderbuyingselling Posted - 1 month ago

$IRTC new insider selling: 1261 shares. http://insiderbuyingselling.com/?t=IRTC

User Image Stock_Titan Posted - 02/29/24

$IRTC iRhythm collaborates with Epic to streamline access to Zio® service and drive more seamless connectivity between clinicians and patients https://www.stocktitan.net/news/IRTC/i-rhythm-collaborates-with-epic-to-streamline-access-to-zio-r-4unyt9kqxyfm.html

User Image lfleur Posted - 2 months ago

$IRTC Why did I just get a check from IRTC? For $62. Stock related?

User Image Estimize Posted - 2 months ago

$IRTC misses the Estimize EPS Consensus by 18c and beats the Estimize Revenue Consensus by $0.79M. Reports FQ4 earnings of -84c EPS and... http://www.estimize.com/irtc/fq4-2023?utm_content=beat_or_miss&utm_medium=tweet&utm_source=stocktwits

User Image DonCorleone77 Posted - 2 months ago

$IRTC iRhythm reports Q4 EPS (84c), consensus (60c) Reports Q revenue $$132.50M , consensus $130.23M."This past year was truly transformational for iRhythm as we made significant strides to advance our mission in our core U.S. market while advancing multiple initiatives that set us up for future growth," said Quentin Blackford, iRhythm's President and CEO. "We realized 20% revenue growth for the full year, driven by record new account onboarding, balanced volume contributions from multiple channels, and the largest product launch in company history. We've made significant progress towards international expansion efforts with recent EU MDR CE mark approval, completed market evaluation in Switzerland, and ongoing review of our Japanese regulatory submission. Moreover, we are also realizing value from our increased focus on operational discipline, achieving more than 180-basis points of improvement in adjusted EBITDA margin for the full year 2023 compared to 2022 and setting us up..."

User Image epsguid Posted - 2 months ago

$IRTC reported a loss of $0.84, consensus was ($0.60) via @eWhispers #epsmiss http://eps.sh/d/irtc

User Image Stock_Titan Posted - 2 months ago

$IRTC iRhythm Technologies Announces Fourth Quarter and Full Year 2023 Financial Results https://www.stocktitan.net/news/IRTC/i-rhythm-technologies-announces-fourth-quarter-and-full-year-2023-yy8w3j49v17n.html

User Image jb02345 Posted - 2 months ago

$IRTC any predictions on earnings ?

User Image Estimize Posted - 2 months ago

$IRTC reports after the close, Estimize Consensus -0.03 EPS and +1.52M Revs compared to WS http://www.estimize.com/irtc/fq4-2023?utm_content=prerelease&utm_medium=tweet&utm_source=stocktwits

User Image swingingtech Posted - 2 months ago

$RNA $IRTC $LNG https://wallstreetwaves.com/notable-wednesday-option-activity-rna-irtc-lng/

User Image Stock_Titan Posted - 2 months ago

$IRTC iRhythm Technologies to Report Fourth Quarter and Full Year 2023 Financial Results on February 22, 2024 https://www.stocktitan.net/news/IRTC/i-rhythm-technologies-to-report-fourth-quarter-and-full-year-2023-mp03j3wgip5n.html

User Image tickeron Posted - 3 months ago

Do you agree with the A.I. prediction? $IRTC Stochastic Oscillator left the overbought zone. View odds of downtrend. https://srnk.us/go/4977589

User Image StockAutomatePro Posted - 3 months ago

$IRTC Looks like the stock is headed for a period of growth according to the chart. We alerted the BUY signal at $111.44 and we were able to close this one with profit at $117.1 😎

User Image TrendyChart Posted - 3 months ago

$IRTC Unveiling hidden gems, stock chart sparkles! 💹 https://thetrendychart.com/

User Image TrendyChart Posted - 3 months ago

$IRTC Patterns on the stock chart weave a tale of potential gains, with technicals orchestrating a symphony of positive signals and a robust, unbroken trend that leads to prosperity and financial success. 🏰 https://trendychart.lpages.co/options/

User Image fin_researcher Posted - 3 months ago

$IRTC what your thoughts about FDA warning letter? https://11thestate.com/cases/irhythm-investor-case

User Image StockAutomatePro Posted - 3 months ago

$IRTC Chart analysis suggests a bullish outlook for the stock. We alerted the BUY signal at $102.61 and we were able to close this one with profit at $112.34 🥳

User Image tickeron Posted - 3 months ago

Do you agree with the A.I. prediction? $IRTC entered Uptrend as Momentum indicator ascends above 0 level. View odds of downtrend. https://srnk.us/go/4964039

User Image StockAutomatePro Posted - 3 months ago

$IRTC The chart is showing a promising outlook for the stock. We alerted the BUY signal at $103.04 and we were able to close this one with profit at $112.91 🔏

User Image UltraAlgo Posted - 3 months ago

$IRTC Sell Rating based off 5 signals, 15-min chart. 💸 UltraAlgo.com https://i.redd.it/b3a5mohbs9bc1.png

User Image AnaChart Posted - 3 months ago

$IRTC https://anachart.com/wp-content/uploads/ana_temp/1704740499_soc-img.jpg

User Image RockyTSTH Posted - 3 months ago

$IRTC iRhythm Technologies shares are trading higher after the company announced a business update and share preliminary Q4 highlights at the J.P. Morgan Healthcare Conference.

Analyst Ratings
JP Morgan Overweight Feb 23, 24
Canaccord Genuity Buy Feb 23, 24
Needham Buy Feb 23, 24
Needham Buy Jan 8, 24
Truist Securities Buy Dec 22, 23
Truist Securities Buy Dec 12, 23
Citigroup Buy Dec 11, 23
Needham Buy Nov 3, 23
Morgan Stanley Overweight Oct 11, 23
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
Murphy Patrick Michael CBO and CLO CBO and CLO Dec 05 Sell 88.82 1,686 149,751 30,751 12/06/23
Blackford Quentin S. President and CEO President and CEO Jun 06 Buy 102.27 9,755 997,644 128,510 12/06/23
Day Mark J. Chief Technology Off.. Chief Technology Officer Aug 03 Option 36.22 486 17,603 55,522 08/04/23
Patterson Chad Chief Commercial Off.. Chief Commercial Officer Aug 02 Sell 100.49 1,896 190,529 30,200 08/02/23
Wilson Daniel G. EVP, Corp Dev Inv Re.. EVP, Corp Dev Inv Rel Jul 03 Sell 103.48 1,490 154,185 33,847 07/03/23
Turakhia Minang EVP, CMO & CSO EVP, CMO & CSO Jul 03 Sell 103.48 988 102,238 19,719 07/03/23
Wilson Daniel G. EVP, Corp Dev Inv Re.. EVP, Corp Dev Inv Rel Mar 29 Sell 125 4,000 500,000 35,337 03/30/23
Murphy Patrick Michael CLO & EVP RA/QA Mrkt.. CLO & EVP RA/QA MrktAcs & Gov Mar 03 Sell 117.23 571 66,938 32,437 03/07/23
Day Mark J. Chief Technology Off.. Chief Technology Officer Mar 03 Sell 117.23 2,116 248,059 54,815 03/07/23
Wilson Daniel G. EVP, Strategy Corp D.. EVP, Strategy Corp Dev Inv Rel Mar 03 Sell 117.23 1,422 166,701 39,337 03/07/23
Devine Douglas Chief Operating Offi.. Chief Operating Officer Mar 03 Sell 117.23 1,473 172,680 29,566 03/07/23
Wilson Daniel G. EVP, Strategy Corp D.. EVP, Strategy Corp Dev Inv Rel Feb 27 Sell 118.63 1,726 204,755 40,759 03/01/23
Devine Douglas Chief Operating Offi.. Chief Operating Officer Feb 27 Sell 118.52 3,518 416,953 31,039 03/01/23
Day Mark J. Chief Technology Off.. Chief Technology Officer Feb 27 Sell 118.56 1,913 226,805 56,931 03/01/23
Murphy Patrick Michael CLO & EVP RA/QA Mrkt.. CLO & EVP RA/QA MrktAcs & Gov Dec 02 Sell 106.78 1,704 181,953 23,726 12/06/22
Blackford Quentin S. President and CEO President and CEO Nov 02 Sell 120.34 12,699 1,528,198 89,280 11/04/22
Devine Douglas Chief Operating Offi.. Chief Operating Officer Sep 29 Sell 125 2,000 250,000 27,702 09/30/22
Wilson Daniel G. EVP, Strategy Corp D.. EVP, Strategy Corp Dev Inv Rel Sep 26 Sell 123.02 3,000 369,060 34,562 09/28/22
Bairey Merz Cathleen Noel Director Director Sep 12 Sell 159.77 90 14,379 4,887 09/14/22
Devine Douglas Chief Operating Offi.. Chief Operating Officer & CFO Jul 07 Sell 114.22 10,109 1,154,650 29,702 07/11/22
Wilson Daniel G. EVP, Strategy Corp D.. EVP, Strategy Corp Dev Inv Rel Jul 05 Sell 108.36 1,428 154,738 37,562 07/07/22
Devine Douglas Chief Operating Offi.. Chief Operating Officer & CFO Jul 05 Sell 107.73 1,239 133,477 39,811 07/07/22
Bairey Merz Cathleen Noel Director Director Jun 14 Sell 111.7608 500 55,880 4,977 06/16/22
Devine Douglas Chief Operating Offi.. Chief Operating Officer & CFO Jul 08 Sell 59.5584 1,212 72,185 30,247 03/22/22
Wilson Daniel G. EVP, Strategy Corp D.. EVP, Strategy Corp Dev Inv Rel Jul 08 Sell 59.5586 2,039 121,440 34,044 03/22/22
Devine Douglas Chief Operating Offi.. Chief Operating Officer & CFO Mar 04 Sell 132.6733 576 76,420 41,955 03/08/22
Vort David A Chief Commercial Off.. Chief Commercial Officer Mar 04 Sell 132.6721 3,161 419,377 27,952 03/08/22
Wilson Daniel G. EVP, Strategy Corp D.. EVP, Strategy Corp Dev Inv Rel Mar 04 Sell 132.6707 1,331 176,585 41,029 03/08/22
King Kevin M Director Director Mar 04 Sell 132.6721 6,815 904,160 250,422 03/08/22
Day Mark J. EVP, Research & Deve.. EVP, Research & Development Mar 04 Sell 132.6723 2,518 334,069 46,705 03/08/22
Vort David A Chief Commercial Off.. Chief Commercial Officer Feb 15 Sell 119.95 2,845 341,258 31,113 02/17/22
Devine Douglas Chief Operating Offi.. Chief Operating Officer & CFO Feb 15 Sell 119.95 4,603 552,130 42,531 02/17/22
Wilson Daniel G. EVP, Strategy Corp D.. EVP, Strategy Corp Dev Inv Rel Feb 15 Sell 119.96 2,652 318,134 42,360 02/17/22
Day Mark J. EVP, Research & Deve.. EVP, Research & Development Feb 15 Sell 119.99 4,062 487,399 49,223 02/17/22